Editorial
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Surg. Mar 27, 2012; 4(3): 45-54
Published online Mar 27, 2012. doi: 10.4240/wjgs.v4.i3.45
A decade in gastric cancer curative surgery: Evidence of progress (1999-2009)
Stefano Rausei, Gianlorenzo Dionigi, Francesca Rovera, Luigi Boni, Caterina Valerii, Luisa Giavarini, Francesco Frattini, Renzo Dionigi
Stefano Rausei, Gianlorenzo Dionigi, Francesca Rovera, Luigi Boni, Caterina Valerii, Luisa Giavarini, Francesco Frattini, Renzo Dionigi, Department of Surgical Sciences, University of Insubria, 21100 Varese, Italy
Author contributions: All the authors contributed to this paper.
Correspondence to: Stefano Rausei, MD, PhD, Department of Surgical Sciences, University of Insubria, Viale L. Borri 57, 21100 Varese, Italy. s.rausei@libero.it
Telephone: +39-332-393229 Fax: +39-332-260260
Received: March 12, 2011
Revised: November 4, 2011
Accepted: November 12, 2011
Published online: March 27, 2012
Abstract

To investigate the progress in evidence-based surgical treatment of non-metastatic gastric cancer, we reviewed the last ten years’ literature. The data used in this review were identified by searches made on MEDLINE, Current Contents, PubMed, and other references taken from relevant original articles (on prospective and retrospective studies) concerning gastric cancer surgery. Only papers published in English between January 1999 and December 2009 were selected. Data from ongoing studies were obtained in December 2009, from the trials registry of the United States National Institutes of Health (http://www.clinicaltrial.gov). The citations list was presented according to evidence based relevance (i.e., randomized controlled trials, prospective studies, retrospective series). In the last ten years, many challenges have been faced relating to the extension of gastric resection and nodal dissection as well as surgical timing, but we found only limited evidence, regardless of latitude of study. The ongoing phase-III trials may provide answers that will be valid for the coming decades, and which may bring definitive answers for the currently unresolved questions.

Keywords: Gastric cancer; Evidence-based surgery; D2 lymphadenectomy; Laparoscopic gastrectomy; Endoscopic treatment; Neoadjuvant therapy